Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

株式のランク #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
株価
$100.60
時価総額
$7.54B
変化(1日)
-1.49%
変化(1年)
49.53%
国
CH
取引 Bachem Holding AG (BANB)

カテゴリー

Healthcare
Bachem Holding AG(BANB)のEPS
2026 時点のEPS TTM: 0
Bachem Holding AGの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Bachem Holding AGのEPS履歴(2002から2026まで)
各年末時点のEPS
年 EPS 変化
2025 $2.50 40.86%
2024 $1.77 -0.69%
2023 $1.78 20.37%
2022 $1.48 -16.61%
2021 $1.78 42.52%
2020 $1.25 54.63%
2019 $0.81 14.96%
2018 $0.70 10.27%
2017 $0.64 6.14%
2016 $0.60 27.46%
2015 $0.47 8.62%
2014 $0.43 10.38%
2013 $0.39 56.07%
2012 $0.25 68.66%
2011 $0.15 -66.84%
2010 $0.45 -32.70%
2009 $0.67 -18.95%
2008 $0.82 -3.00%
2007 $0.85 45.84%
2006 $0.58 27.75%
2005 $0.46 10.28%
2004 $0.41 -8.68%
2003 $0.45 25.23%
2002 $0.36 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
$17.32 -
US
$-7.98 -
US
$-5.29 -
AU
$27.74 -
NL
- -
CH